Table 4.
Outcome | Functional Impairment Categories | No. of Medications | Events / n | Risk (%) | Crude OR (95% CI) | IPTW OR (95% CI) | P for Effect Modification* |
---|---|---|---|---|---|---|---|
Mortality | No to Mild Impairment | 1 | 67 / 600 | 11.2 | Reference | Reference | 0.79 |
2 | 51 / 569 | 9.0 | 0.78 (0.53–1.15) | 0.92 (0.62–1.37) | |||
3 or 4 | 32 / 522 | 6.1 | 0.52 (0.34–0.81) | 0.80 (0.49–1.29) | |||
Moderate to Severe Impairment | 1 | 161 / 1,225 | 13.1 | Reference | Reference | ||
2 | 127 / 1,003 | 12.7 | 0.96 (0.75–1.23) | 1.02 (0.78–1.33) | |||
3 or 4 | 71 / 868 | 8.2 | 0.59 (0.44–0.79) | 0.72 (0.52–0.99) | |||
Rehospitalization | No to Mild Impairment | 1 | 134 / 600 | 22.3 | Reference | Reference | 0.65 |
2 | 140 / 569 | 24.6 | 1.11 (0.84–1.46) | 1.11 (0.83–1.49) | |||
3 or 4 | 128 / 522 | 24.5 | 1.07 (0.81–1.41) | 1.13 (0.83–1.55) | |||
Moderate to Severe Impairment | 1 | 315 / 1,225 | 25.7 | Reference | Reference | ||
2 | 273 / 1,003 | 27.2 | 1.05 (0.87–1.27) | 0.95 (0.78–1.17) | |||
3 or 4 | 233 / 868 | 26.8 | 0.98 (0.80–1.20) | 0.89 (0.70–1.14) | |||
Functional Decline | No to Mild Impairment | 1 | 46 / 600 | 7.7 | Reference | Reference | 0.44 |
2 | 71 / 569 | 12.5 | 1.67 (1.13–2.48) | 1.47 (0.96–2.28) | |||
3 or 4 | 68 / 522 | 13.0 | 1.70 (1.14–2.53) | 1.45 (0.92–2.29) | |||
Moderate to Severe Impairment | 1 | 213 / 1,225 | 17.4 | Reference | Reference | ||
2 | 203 / 1,003 | 20.2 | 1.20 (0.97–1.50) | 0.95 (0.74–1.20) | |||
3 or 4 | 219 / 868 | 25.2 | 1.52 (1.22–1.88) | 1.02 (0.79–1.32) |
Abbreviations: OR, odds ratio; CI, confidence interval; IPTW, inverse probability of treatment-weighted.
Presented for the IPTW estimates only.